News Agency
Men's Weekly

Nuance Pharma Announces Dosing of First Patient in ENHANCE - China Phase III Trial for Chronic Obstructive Pulmonary Disease ("COPD")

  • Written by PR Newswire

SHANGHAI, April 7, 2023 /PRNewswire/ -- Nuance Pharma ("the Company") announces dosing of first patient in the ENHANCE - China Phase III Trial for the maintenance treatment of chronic obstructive pulmonary disease ("COPD") of its novel solution Ensifentrine in mainland China.

Ensifentrine is a first-in-class, selective, dual inhibitor of the...

Read more: Nuance Pharma Announces Dosing of First Patient in ENHANCE - China Phase III Trial for Chronic...

Insurance Industry Innovation Through VR Training

Australia's insurance industry, managing over $120 billion in annual premiums, operates at the intersection of financial services and human crisis. Insurance professionals must navigate emotionally charged situations daily, from claim denials to disaster responses. Leading insurers are now implementing best... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion